Research Article | Open Access
Martin Stattin, Julia Forster, Ahmed Daniel, Alexandra Graf, Katharina Krepler, Siamak Ansari-Shahrezaei, "Relationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration", Journal of Ophthalmology, vol. 2019, Article ID 4806061, 8 pages, 2019. https://doi.org/10.1155/2019/4806061
Relationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration
Purpose. To assess the relationship between signs of activity in exudative neovascular age-related macular degeneration (nAMD) following anti-vascular endothelial growth factor (anti-VEGF) treatment and morphology of choroidal neovascularization (CNV) based on neovascular density as imaged using swept source-optical coherence tomography angiography (SS-OCTA) in a qualitative manner. Methods. A single-cohort retrospective data analysis from one tertiary eye care center. Seventy-seven eyes of 72 patients were included and their charts reviewed which had been started on intravitreal injections with anti-VEGF for nAMD at least one year prior to enrollment. Clinically active disease was evaluated by slit-lamp fundus examination and spectral domain-OCT B-scans. Morphological appearance in SS-OCTA was characterized based on 5 different criteria and subsequently divided into 3 groups: predominantly hyperdense, minimally hyperdense, and hypodense lesions. Results. Fifty-eight eyes (75%) were considered clinically active and 19 eyes (25%) clinically inactive. CNV was depicted in 71 eyes (92%) by SS-OCTA and separated accordingly into predominantly hyperdense (32%), minimally hyperdense (34%), and hypodense lesions (34%). A borderline significant difference in the probability of neovascular activity for predominantly hyperdense lesions compared to hypodense lesions was detected (). Conclusions. Hyperdense choroidal neovascularization based on qualitative assessment of flow density showed a significant relation to active disease. Inactivity could not be matched adequately. This study demonstrated the potential usefulness of SS-OCTA for guidance of treatment in age-related macular degeneration.
To date, dilated fundus examination, fluorescein angiography (FA), indocyanine green angiography (ICGA), and optical coherence tomography (OCT) were generally employed for the diagnosis, classification, and therapeutic guidance of age-related macular degeneration (AMD) complicated by choroidal neovascularization (CNV) .
OCT angiography (OCTA) is a relatively new noninvasive imaging modality, based on high-frequency scanning for the detection of red blood cell movement . This novel technique provides the potential to visualize depth-resolved blood flow in the retinal microcirculation without the risk of dye-associated adverse events such as nausea or anaphylaxis caused by FA/ICGA . Furthermore, OCTA can separately detect the superficial vascular and the deep vascular networks that are generally overlaid and appear fused in standard angiographies . However, the utility of OCTA alone in the detection and observation of neovascular (n)AMD is still under debate . Previous studies have demonstrated the superiority of FA/ICGA to OCTA concerning sensitivity and specificity in the diagnosis of untreated CNV [6, 7]. Nevertheless, the isolation of CNV morphology and its repeatability in OCTA scans indicate the potential capacity of this method in the qualitative assessment and monitoring of the response to antiangiogenic treatment in this chronic disease [8–10].
The purpose of this study was to evaluate a new qualitative CNV classification based on neovascular density imaged by swept source (SS)-OCTA and to assess its relevance regarding clinical activity. A significant relationship between CNV morphology and nAMD subsequent to anti-vascular endothelial growth factor (anti-VEGF) treatment would benefit daily routine and ease decision-making.
2. Materials and Methods
Consenting patients who had commenced treatment with intravitreal injections (IVIs) of anti-VEGF for nAMD that was initially diagnosed by fluorescein angiography ≥12 months prior to enrollment and who were followed up from March to July 2017 at our tertiary retina center (Medical Retina Unit, Department of Ophthalmology; Rudolf Foundation Hospital Vienna; Karl Landsteiner Institute for Retinal Research and Imaging) additionally underwent OCTA imaging at the time of recruitment. The study protocol adhered to the tenets of the Declaration of Helsinki. Standard follow-up included best-corrected visual acuity (BCVA) measurement using early treatment diabetic retinopathy study (ETDRS, 4 m) charts, dilated slit-lamp fundus examination (Haag-Streit AG, Bern, Switzerland) by a senior medical retina specialist and imaging with spectral domain (SD)-OCT (Zeiss Cirrus HD 4000, Carl Zeiss Meditec AG, Jena, Germany). Inactive disease was defined as (1) absence of fluid (intraretinal, subretinal or subretinal pigment epithelium) on SD-OCT B-scans, (2) no new macular hemorrhage on biomicroscopy, and (3) no intravitreal treatment with anti-VEGF within the past 9 months. If all criteria applied to an eye, the lesion was considered as inactive.
SD-OCT B-scans were acquired using the central 1 mm (500 μm radius) zone for accurate centration within the ETDRS grid. The scan was excluded from the analysis if adjustment of these parameters was not possible due to severe distortion of the retinal architecture or motion artefacts due to absent fixation.
Consenting patients were examined with a beta-version of Topcon’s DRI Triton SS-OCTA (Topcon Corporation, Tokyo, Japan) device operating at 100,000 A scans per s on 1 mW input power. One notable feature is its OCTA Ratio Analysis, a full-spectrum algorithm that relies on the detection of motion contrast to create a decorrelation signal. Topcon’s OCTA analysis software (IMAGEnet 6) provided three-dimensional (3D) 3 × 3 mm, 4.5 × 4.5 mm, 6 × 6 mm, and even 9 × 9 mm macular cubes with automated subdivision into four different en-face segments: the superficial inner retinal plexus, the deep inner retinal plexus, the outer retina, and the choriocapillaris. The segments were concordantly matched with SS-OCT B-scans to visualize the layer of the neovascular complex layer. Each B-scan consisted of 320 A scans and each volume (3 × 3 mm, 4.5 × 4.5 mm, 6 × 6 mm) consisted of 320 B-scans, respectively, of 512 B-scans (9 × 9 mm). The pixel size ranged from 9.4 to 18.8 μm transversal resolutions according to the selected cube. The digital axial resolution was 2.6 μm. Acquired volumes in 4.5 × 4.5 mm cubes as standard of care were generated for each eye by orthogonal registration centered at the macula and augmented by additional sizes. If more than one cube size was applied, the scan with the highest resolution (i.e., the smallest possible cube size) imaging the full lesion was analyzed. The integrated artefact removal option for projection artefacts was applied to the choriocapillaris and the outer retina slab. The integrated software was used to delineate the outer retina and choriocapillaris segments. Automated segmentation lines were manually altered and moved progressively in both directions by a skilled resident to ensure visualization of all circumscribed CNV borders.
A medical retina fellow, who was blinded to the funduscopy and Zeiss’ SD-OCT B-scans, had access to the entire volumetric dataset and identified neovascular networks by observing multiple 2D en-face scans and categorized them into three groups based on the presence or absence of five established morphological criteria:
(1) Numerous branching capillaries between major vessels separating the lesion area into fractals, (2) end-to-end anastomoses or intervascular anastomoses within the lesion, (3) arcades or vascular loops at the vessel termini, (4) major, well-defined filamentous vessels, and (5) peri- or intralesional nonvascularized hypointense halos surrounding or embedding the CNV membrane only if masking by blood, fluid, pigment, or thresholding could be excluded .
If neovascular flow was detected, lesions were classified as follows:(1)Predominantly hyperdense if multiple branching capillaries, peripheral arcades, loops, and anastomoses predominated in >50% of the maximum lesion area depicted in the most suitable 2D en-face SS-OCTA segmentation image (Figure 1).(2)Minimally hyperdense if networks consistent of branching capillaries, anastomoses, and peripheral arcades were found in <50% of the lesion size (Figure 2).(3)Hypodense if filamentous well-defined vessels with blunt endings or ill-defined capillaries were depicted in otherwise nonvascularized halos (Figures 3 and 4).
A senior medical retina fellow independently surveyed and categorized the pattern distribution. An attending who was not affiliated with the study group was consulted for adjudication in case of disagreement or discordant assignment to one of the classes.
Age, sex, and number of administered IVIs were drawn from patient charts. Univariate logistic regression analyses were applied to detect the impact of branching capillaries, anastomoses, peripheral arcades, well-defined vessels, nonvascularized halos, and vascular density on the probability of activity. All significant factors in the univariate analysis were re-evaluated in a multivariable logistic regression model. To account for the small number of events in no flow, Firth’s penalized likelihood approach was used. Statistical analysis was performed using R Studio 1.0.136 and SAS 9.4. Figures were developed using Affinity Photo V1.5.2.
Eighty-four eyes of 78 patients with a history of nAMD based on multimodal imaging met the inclusion criteria. Seven eyes were excluded from the analysis due to poor image quality. Hence, 77 eyes of 72 patients were enrolled in this study, 54 (70%) of whom were female. The mean age was 80.3 ± 8.2 (standard deviation) years. Laterality was distributed evenly (52% right eyes). The mean follow-up time was 5.4 ± 2.0 years after the onset of nAMD with an average of 20.2 ± 12.5 IVIs of anti-VEGF in total.
Fifty-eight (75%) clinically active eyes presented with fluid on SD-OCT B-scans or funduscopic evidence of new hemorrhage. Nineteen eyes (25%) remained clinically silent at the time of recruitment. CNV was depicted in 71 of 77 eyes (92%) by SS-OCTA. Fifty-four of 58 eyes (93%) with clinical signs of neovascular activity exhibited a definite CNV membrane on SS-OCTA. In addition, 17 of 19 silent eyes (90%) exhibited a CNV formation on SS-OCTA. No statistically significant relationship between the clinical status of nAMD and the detection rate of CNV on SS-OCTA could be observed (). Sex (), age (), and laterality () did not have an impact on flow detection.
Twenty eyes (37%) with active and three eyes (18%) with inactive disease were characterized as predominantly hyperdense (Figure 1). Moreover, 20 (37%) clinically active and four (24%) clinically inactive eyes were described as minimally hyperdense (Figure 2). Fourteen eyes (26%) with active and ten eyes (59%) with inactive disease were labeled as hypodense (Figures 3 and 4). In the multivariate analysis, a borderline significant difference regarding clinical activity was found between predominantly hyperdense and hypodense lesions (). No significant difference between the predominantly and minimally hyperdense () as well as the minimally hyperdense and hypodense () groups could be detected. Capillaries, anastomoses, and arcades were more frequently observed in all eyes independent of their clinical status, while major vessels and nonvascularized tissue were more often absent in all eyes. The same distribution was detected in eyes with active nAMD but not in quiescent nAMD as summarized in Table 1. Nevertheless, no parameter alone exhibited a significant relationship with the clinical activity of nAMD.
nAMD = neovascular age-related macular degeneration.
Sex (), age (), and laterality () had no significant impact on clinical activity.
The relationship between the vascular density of CNV based on SS-OCTA en-face images and clinical signs of activity in nAMD after previous treatment with anti-VEGF was investigated and a borderline significant difference could be detected (). Other descriptions of different CNV formations in OCTA and their incorporation into clinical practice have previously been investigated with varying results [12–14]. In concordance with the presence or absence of findings first described by Coscas in 2015, we attempted to develop a qualitative classification algorithm based on neovascular density as a predictive factor for clinical activity . Herein, all employed characteristics were independently related to clinical signs of neovascular activity and none were significant (Table 1). However, criteria such as branching capillaries, end-to-end anastomoses, and peripheral arcades were continuously found in active disease and were more frequently missing in inactive eyes. Based on our findings regarding the distribution of smaller and more numerous vessels towards activity, a higher density could be assumed. Topcon’s SS-OCTA device is currently not equipped with a quantification algorithm, which would divide intervascular planes into fractals, determine the area size, and count the numbers of fractals. Therefore, our classification concept was a qualitative assessment ideally similar to the well-established assessment used in conventional angiography known for decades. Independent reading centers were used to classify neovascularization based on the quality of dye distribution (e.g., early leakage and hot spot) within an en-face 2D imprint of the retinal and choroidal vasculature.
In our study, 37% (20/54) of predominantly hyperdense lesions were associated with active disease and 18% (3/17) with inactive disease. In addition, 20/54 (37%) active eyes showed minimal hyperdensity in contrast to 4/17 (24%) inactive eyes. The distribution of minimally hyperdense lesions indicated a low number of inactive eyes as the substantial reason for the lack of significance rather than a misinterpretation of data. A tendency towards significance () between the distribution of predominantly hyperdense and hypodense lesions was established. Nevertheless, the investigated SS-OCTA-based classification failed to adequately distinguish between activity status and hypodensity as 26% (14/54) with active and 59% (10/17) with inactive disease were labeled as hypodense. Hypodensity due to a hypothesized maturation of the vasculature could not be significantly related to inactive AMD . Spaide described an alteration of the disease by targeting new vessel growth. Regression of the most recent vascular elements was possible with retreatment while more prominent vessels could not be eradicated and still exhibited activity to some extent. The discordance between hypodense patterns and nAMD activity requires further enhancement.
Grassniklaus and Green proposed a compensatory response of the CNV architecture as a recapitulation of the choriocapillaris perfusion in eyes compromised by nAMD . They stated that main CNV vessels were present even when the disease was controlled and did not necessarily exacerbate the disease severity. In concordance with their findings, the CNV detection rate on SS-OCTA in this study was high (92%) in eyes complicated by nAMD subsequent to anti-VEGF treatment, independent of the clinical status. These data were consistent with those of other groups investigating the persistence of neovascular formation in inactive disease over time [17, 18]. In addition to well-defined vessels, nonvascularized halos were more often absent in both active and inactive diseases. These halos were part of the lesions and resembled areas of nonperfusion of the underlying choriocapillaris or detection loss due to obscuration . The absence of one of the characteristics was not significantly related to inactivity. Similar to our definition of inactive CNV, “quiescent” CNV is a nonexudative form of nAMD that develops over time, and its growth is currently under debate as a predictive factor of activity or reduced retinal sensitivity . Al-Sheikh et al. recently published their results on the qualitative and quantitative features of active and quiescent lesions on OCTA . They compared the same biomarkers of active lesions before and after treatment to quiescent lesions and even quantified the pattern complexity by the fractal dimension. Roberts et al. differentiated the vascular features of CNV complexes based on a quantitative analysis (AngioTool) in two patient groups, which were divided only by their injection intervals (< or >6 weeks) and found no significance . We used a similar approach to classify the vascular network complexity in a qualitative manner. No exact definition yet exists for eyes in remission. In our opinion, suspension of retreatment in previously active nAMD for ≥9 months indicated inactivity. Nevertheless, a mismatch still exists between hypodensity elaborated by SS-OCTA and the activity of displayed vessels in vivo, hypothecating that the new vasculature could still leak and take even longer to reach maturation.
Additionally, CNV structures were detected by different OCTA devices. Liang used the AngioVue SD-OCTA system (Optovue, Inc, Fremont, CA) operating at 70,000 A scans per s with 3 × 3 mm cubes in 2016 . We previously investigated the detection rate of SS-OCTA in treatment-naïve nAMD and found it to be around 76% . SS-OCTA’s higher wavelength and A scan rate result in deeper penetration and better contrast of small neovascular structures. Novais et al. found significantly larger CNV areas on SS-OCTA images than on SD-OCTA, proposing a more accurate visualization of CNV .
The impact of subretinal fibrosis and atrophy on image quality and projection artefacts on OCTA targets a different problem . Based on our research, these factors had no significant influence on the detection rate of CNV on SS-OCTA (geographic atrophy ; fibrosis ). Resegmentation of the corresponding layers in the affected eyes was frequent and crucial to differentiate blood flow due to neovascularity and choriocapillaris dropout within the choroidal vasculature.
This study has several limitations. The data were analyzed retrospectively. No endpoints for comparison of independently armed cohorts were proposed. Therefore, conclusions regarding the sensitivity or specificity of the tested device could not be drawn. Multiple graders would be sufficient to reproduce intergrader reliability for testing in a prospective study design. Another limitation was the qualitative characterization of CNV structures on SS-OCTA. A small number of eyes in remission were insufficient for the quantitative analysis of influencing factors and may lead to misinterpretation of morphological criteria in silent eyes. Only prototypes for quantification software currently exist and their value is yet to be confirmed in a reading center. For the most part, all attempts were analyzed using plane 2D segments, although it is well known that CNV growth occurs not only horizontally, but also vertically. It would therefore be appropriate to quantify vessel density in a predefined 3D space. However, no characteristics of CNV on OCTA have been standardized to date. To our knowledge, this is the first attempt to use OCTA-based morphological criteria for vascular density in a clinically applicable qualitative grading system.
In summary, the herein presented classification can partially replace current standard follow-up procedures. We were able to gain a better understanding of the development of the disease. Hyperdensity acts as an indicator of activity, but hypodensity does not necessarily reflect inactivity. The development of an objective qualitative and quantitative grading method is necessitated in a prospective study to confirm the reproducibility and reliability of SS-OCTA findings.
The datasets used and/or analyzed to support the findings of this study are available from the corresponding author on reasonable request.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
This research was performed as part of the employment of the authors, namely, the Rudolf Foundation Hospital and the Karl Landsteiner Institute for Retinal Research and Imaging. The data were also presented at Euretina in September 2018. Carl Glittenberg was a Senior Clinical Advisor of Topcon Europe at the time of recruitment and study elaboration. He was listed as a co-author on the abstract for the presentation at the Austrian ophthalmological conference (ÖOG) in May 2018. He wishes not be listed as a co-author in case of publication.
Conflicts of Interest
The authors declare that there are no conflicts of interest regarding the publication of this article.
Each author certifies that he or she has made substantial contribution to the work reported in this manuscript to all of the following: (1) conception and design, acquisition of data, and analysis and interpretation of data, (2) drafting the article and revising it critically for important intellectual content, (3) final approval of the version to be published, (4) and agreement to be accountable for all aspects of the work in ensuring that all questions related to the accuracy and integrity of the work are appropriately investigated and resolved.
The computing and postprocessing of the figures were supported by Senior Clinical Advisor Carl Glittenberg, a Topcon employee at the time of recruitment and study elaboration.
- L. S. Lim, P. Mitchell, J. M. Seddon, F. G. Holz, and T. Y. Wong, “Age-related macular degeneration,” The Lancet, vol. 379, no. 9827, pp. 1728–1738, 2012.
- S. Makita, Y. Hong, M. Yamanari, T. Yatagai, and Y. Yasuno, “Optical coherence angiography,” Optics Express, vol. 14, no. 17, pp. 7821–7840, 2006.
- L. A. Yannuzzi, K. T. Rohrer, L. J. Tindel et al., “Fluorescein angiography complication survey,” Ophthalmology, vol. 93, no. 5, pp. 611–617, 1986.
- M. C. Savastano, B. Lumbroso, and M. Rispoli, “In vivo characterization of retinal vascularization morphology using optical coherence tomography angiography,” Retina, vol. 35, no. 11, pp. 2196–2203, 2015.
- K. Sambhav, S. Grover, and K. V. Chalam, “The application of optical coherence tomography angiography in retinal diseases,” Survey of Ophthalmology, vol. 62, no. 6, pp. 838–866, 2017.
- J. Gong, S. Yu, Y. Gong, F. Wang, and X. Sun, “The diagnostic accuracy of optical coherence tomography angiography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography,” Journal of Ophthalmology, vol. 2016, Article ID 7521478, 8 pages, 2016.
- D. Ahmed, M. Stattin, A. Graf et al., “Detection of treatment-naive choroidal neovascularization in age-related macular degeneration by swept source optical coherence tomography angiography,” Retina, vol. 38, no. 11, pp. 2143–2149, 2018.
- N. W. Muakkassa, A. T. Chin, T. de Carlo et al., “Characterizing the effect of anti-vascular endothelial growth factor therapy on treatment-naive choroidal neovascularization using optical coherence tomography angiography,” Retina, vol. 35, no. 11, pp. 2252–2259, 2015.
- B. Lumbroso, M. Rispoli, and M. C. Savastano, “Longitudinal optical coherence tomography-angiography study of type 2 naive choroidal neovascularization early response after treatment,” Retina, vol. 35, no. 11, pp. 2242–2251, 2015.
- N. Phasukkijwatana, A. C. S. Tan, X. Chen, K. B. Freund, and D. Sarraf, “Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy,” British Journal of Ophthalmology, vol. 101, no. 5, pp. 597–602, 2017.
- G. J. Coscas, M. Lupidi, F. Coscas, C. Cagini, and E. H. Souied, “Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular degeneration,” Retina, vol. 35, no. 11, pp. 2219–2228, 2015.
- Y. Jia, S. T. Bailey, D. J. Wilson et al., “Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration,” Ophthalmology, vol. 121, no. 7, pp. 1435–1444, 2014.
- M.-L. Farecki, M. Gutfleisch, H. Faatz et al., “Characteristics of type 1 and 2 CNV in exudative AMD in OCT-angiography,” Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 255, no. 5, pp. 913–921, 2017.
- M. C. Liang, T. E. de Carlo, C. R. Baumal et al., “Correlation of spectral domain optical coherence tomography angiography and clinical activity in neovascular age-related macular degeneration,” Retina, vol. 36, no. 12, pp. 2265–2273, 2016.
- R. F. Spaide, “Choroidal neovascularization,” Retina, vol. 37, no. 4, pp. 609-610, 2017.
- H. E. Grassniklaus and W. R. Green, “Choroidal neovascularization,” American Journal of Ophthalmology, vol. 137, no. 3, pp. 496–503, 2004.
- Y. Ichiyama, T. Sawada, Y. Ito, M. Kakinoki, and M. Ohji, “Optical coherence tomography angiography reveals blood flow in choroidal neovascular membrane in remission phase of neovascular age-related macular degeneration,” Retina, vol. 37, no. 4, pp. 724–730, 2017.
- M. A. Wirth, F. Freiberg, M. Pfau, J. Wons, M. D. Becker, and S. Michels, “Optical coherence tomography angiography in age-related macular degeneration: persistence of vascular network in quiescent choroidal neovascularization,” Acta Ophthalmologica, vol. 95, no. 4, pp. 428–430, 2017.
- M. Rispoli, M. C. Savastano, and B. Lumbroso, “Quantitative vascular density changes in choriocapillaris around CNV after anti-VEGF treatment: dark halo,” Ophthalmic Surgery, Lasers and Imaging Retina, vol. 49, no. 12, pp. 918–924, 2018.
- G. Querques, M. Srour, N. Massamba et al., “Functional characterization and multimodal imaging of treatment-naïve “quiescent”choroidal neovascularization,” Investigative Opthalmology & Visual Science, vol. 54, no. 10, pp. 6886–6892, 2013.
- M. Al-Sheikh, N. A. Iafe, N. Phasukkijwatana, S. R. Sadda, and D. Sarraf, “Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography,” Retina, vol. 38, no. 2, pp. 220–230, 2018.
- P. K. Roberts, P. L. Nesper, M. K. Gill, and A. A. Fawzi, “Semiautomated quantitative approach to characterize treatment response in neovascular age-related macular degeneration,” Retina, vol. 37, no. 8, pp. 1492–1498, 2017.
- E. A. Novais, M. Adhi, E. M Moult et al., “Choroidal neovascularization analyzed on ultrahigh-speed swept-source optical coherence tomography angiography compared to spectral-domain optical coherence tomography angiography,” American Journal of Ophthalmology, vol. 164, pp. 80–88, 2016.
- A. Miere, O. Semoun, S. Y. Cohen et al., “Optical coherence tomography angiography features of subretinal fibrosis in age-related macular degeneration,” Retina, vol. 35, no. 11, pp. 2275–2284, 2015.
Copyright © 2019 Martin Stattin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.